(Q41508310)

English

Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma

scientific article published on 5 November 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma (English)

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

phase III clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Lai-ping Zhong

1

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Chen-ping Zhang

2

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Guo-xin Ren

3

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Wei Guo

4

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

William N William

5

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Jian Sun

6

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Han-guang Zhu

7

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Wen-yong Tu

8

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Jiang Li

9

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Yi-li Cai

10

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Li-zhen Wang

11

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Xin-dong Fan

12

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Zhong-he Wang

13

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Yong-jie Hu

14

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Tong Ji

15

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Wen-jun Yang

16

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Wei-min Ye

17

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Jun Li

18

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Yue He

19

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Yan-an Wang

20

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Li-qun Xu

21

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Bo-song Wang

22

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Merrill S Kies

23

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

J Jack Lee

24

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Jeffrey N Myers

25

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Zhi-yuan Zhang

26

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

language of work or name

0 references

publication date

5 November 2012

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Journal of Clinical Oncology

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

31

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

6

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

744-751

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Novel biomarker panel predicts prognosis in human papillomavirus-negative oropharyngeal cancer: an analysis of the TAX 324 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5569675

10 June 2018

Phase II trial of induction chemotherapy followed by surgery for squamous cell carcinoma of the oral tongue in young adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5569675

10 June 2018

Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5569675

10 June 2018

TP53 mutations and pathologic complete response to neoadjuvant cisplatin and fluorouracil chemotherapy in resected oral cavity squamous cell carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5569675

10 June 2018

EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5569675

10 June 2018

Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5569675

10 June 2018

Global cancer statistics, 2002

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5569675

10 June 2018

The World Oral Health Report 2003: continuous improvement of oral health in the 21st century--the approach of the WHO Global Oral Health Programme

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5569675

10 June 2018

Oral cancer and precancerous lesions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5569675

10 June 2018

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5569675

10 June 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5569675

10 June 2018

Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5569675

10 June 2018

beta-Tubulin-II expression strongly predicts outcome in patients receiving induction chemotherapy for locally advanced squamous carcinoma of the head and neck: a companion analysis of the TAX 324 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5569675

19 August 2018

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5569675

19 August 2018

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5569675

19 August 2018

Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5569675

19 August 2018

Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5569675

19 August 2018

Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5569675

19 August 2018

Long-term quality of life after treatment of laryngeal cancer. The Veterans Affairs Laryngeal Cancer Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5569675

19 August 2018

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5569675

30 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5569675

2 December 2018

p53 gene status as a predictor of tumor response to induction chemotherapy of patients with locoregionally advanced squamous cell carcinomas of the head and neck

1 reference

https://pubmed.ncbi.nlm.nih.gov/23129742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Treatment and prognosis of gingival carcinoma: a report of 116 cases]

1 reference

https://pubmed.ncbi.nlm.nih.gov/23129742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Survival analysis of 229 patients with advanced squamous cell carcinoma of the oral tongue]

1 reference

https://pubmed.ncbi.nlm.nih.gov/23129742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2012.43.8820

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41508310&oldid=1922523807"